Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Irma Bisceglia(Azienda Ospedaliera San Camillo-Forlanini), Furio Colivicchi(Ospedale San Filippo Neri), Vito Racanelli(University of Trento), Fabio Calabrò(Carlo Forlanini Hospital), Chiara Lestuzzi, Fabrizio Oliva(Associazione Nazionale Medici Cardiologi Ospedalieri), Luigi Tarantini(Santa Maria Nuova Hospital), Damiana Fiscella, Giuseppina Gallucci, Stefania Angela Di Fusco(ASL Roma), Massimiliano Camilli(Università Cattolica del Sacro Cuore), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonella Moreo(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Fabiana Lucà(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Raffaella Mistrulli(Sapienza University of Rome), Michele Massimo Gulizia(Ospedale Garibaldi), Giuseppe Curigliano(European Institute of Oncology), Andrea Camerini(Ospedale Versilia), Domenico Gabrielli(Azienda Ospedaliera San Camillo-Forlanini), Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Leonardo De Luca(Mount Sinai Hospital), Alessandro Inno(Ospedale Sacro Cuore Don Calabria), Stefano Oliva(Istituto Tumori Bari), Nicola Maurea(Cancer Institute (WIA)), Fabio Maria Turazza, Iris Parrini(A. O. Ordine Mauriziano di Torino), Nicola Silvestris(University of Messina), Antonio Russo(University of Palermo), Giulia Russo, Giuseppina Rosaria Rita Ricciardi, Maria Laura Canale(Ospedale Versilia), Lorena Incorvaia(University of Palermo), Saverio Cinieri(Ospedale A. Perrino)
Cited by 17
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k